Alka Batycky
Plus aucun poste en cours
Profil
Alka Batycky served as the Director at Landos Biopharma, Inc. from 2023 to 2024.
Prior to that, she held the position of Vice President-Program & Alliance Management at AMAG Pharmaceuticals, Inc. and Vice President-Portfolio & Alliance Management at Warp Drive Bio, Inc. She also served as the Chief Development Officer at Finch Therapeutics Group, Inc. from 2022 to 2023 and at Ohana Biosciences, Inc. from 2019 to 2021.
Dr. Batycky obtained her undergraduate and doctorate degrees from the University of London.
Anciens postes connus de Alka Batycky
| Sociétés | Poste | Fin |
|---|---|---|
| LANDOS BIOPHARMA, INC. | Directeur/Membre du Conseil | 23/05/2024 |
| FINCH THERAPEUTICS GROUP, INC. | Corporate Officer/Principal | 31/03/2023 |
Ohana Biosciences, Inc.
 Ohana Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ohana Biosciences, Inc. operates early stage biotechnology firm. The company is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/04/2021 |
Warp Drive Bio, Inc.
 Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
| AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formation de Alka Batycky
| University of London | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Health Services |
| LANDOS BIOPHARMA, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
Warp Drive Bio, Inc.
Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA. | Commercial Services |
Ohana Biosciences, Inc.
Ohana Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ohana Biosciences, Inc. operates early stage biotechnology firm. The company is headquartered in Cambridge, MA. | Commercial Services |
